ديبو-ميدرول
Depo-Medrol (methylprednisolone acetate) Sterile Aqueous Suspension is an anti-inflammatory corticosteroid indicated for the treatment of pain and lameness associated with osteoarthritis in horses, and for inflammatory and allergic conditions in dogs and cats.
الشكل الصيدلاني
Suspension
نوع المنتج
دواء
الشركة المصنعة
الحجم
Vials containing 20 mg/mL or 40 mg/mL methylprednisolone acetate in 5 mL, 10 mL, or 20 mL multi-dose vials
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Horse | Usual initial dose is 200 mg (range 40 to 240 mg) intra-articular or intramuscular | Intra-articular or Intramuscular (IM) | Repeated at intervals depending on clinical response |
| Dog | Average dose is 20 mg (1 to 2 mg/kg) IM; range 2 to 40 mg | Intramuscular (IM) or Subcutaneous | Weekly or as needed based on condition |
| Cat | Average dose is 10 to 20 mg (range 1 to 2 mg/kg) IM | Intramuscular (IM) | Every 1 to 3 weeks as needed |
لا توجد معلومات سحب متاحة.
Alleviation of pain and lameness associated with localized arthritic conditions and generalized osteoarthritis in horses.
Treatment of allergic and inflammatory dermatoses, arthritic conditions, and otitis externa in dogs and cats.
Management of feline asthma and eosinophilic granuloma complex in cats.
Do not use in horses with acute infectious arthritis, septic conditions, or systemic fungal infections.
Do not administer intravenously.
Glucocorticoid administration in horses carries risk of laminitis.
Long-term systemic use may lead to hypothalamic-pituitary-adrenal (HPA) axis suppression, polyuria, polydipsia, and iatrogenic Cushingoid signs.
Ensure strict aseptic technique when performing intra-articular injections.
Polyuria, polydipsia, increased appetite, weight gain, transient muscle weakness, and risk of laminitis in equines.
Depo-Medrol Prescribing Information
نشرة20 mg/mL
لا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.